These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 26225729)
41. The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis. Buckley ML; Ramji DP Biochim Biophys Acta; 2015 Jul; 1852(7):1498-510. PubMed ID: 25887161 [TBL] [Abstract][Full Text] [Related]
42. Localization in situ of the co-stimulatory molecules B7.1, B7.2, CD40 and their ligands in normal human lymphoid tissue. Vyth-Dreese FA; Dellemijn TA; Majoor D; de Jong D Eur J Immunol; 1995 Nov; 25(11):3023-9. PubMed ID: 7489738 [TBL] [Abstract][Full Text] [Related]
43. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Leifeld L; Trautwein C; Dumoulin FL; Manns MP; Sauerbruch T; Spengler U Am J Pathol; 1999 Jun; 154(6):1711-20. PubMed ID: 10362796 [TBL] [Abstract][Full Text] [Related]
44. Defects in regulation of local immune responses resulting in atherosclerosis. Ferencík M; Stvrtinová V; Hulín I Clin Dev Immunol; 2005 Sep; 12(3):225-34. PubMed ID: 16295529 [TBL] [Abstract][Full Text] [Related]
45. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Lievens D; Eijgelaar WJ; Biessen EA; Daemen MJ; Lutgens E Thromb Haemost; 2009 Aug; 102(2):206-14. PubMed ID: 19652870 [TBL] [Abstract][Full Text] [Related]
46. Leukotrienes as a molecular link between obstructive sleep apnoea and atherosclerosis. Stanke-Labesque F; Pépin JL; Gautier-Veyret E; Lévy P; Bäck M Cardiovasc Res; 2014 Feb; 101(2):187-93. PubMed ID: 24204032 [TBL] [Abstract][Full Text] [Related]
47. Innate sensors of pathogen and stress: linking inflammation to obesity. Jin C; Flavell RA J Allergy Clin Immunol; 2013 Aug; 132(2):287-94. PubMed ID: 23905917 [TBL] [Abstract][Full Text] [Related]
48. IL-17 and Th17 cells in atherosclerosis: subtle and contextual roles. Taleb S; Tedgui A; Mallat Z Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):258-64. PubMed ID: 25234818 [TBL] [Abstract][Full Text] [Related]
50. The CD40/CD40L system: a new therapeutic target for disease. Zhang B; Wu T; Chen M; Zhou Y; Yi D; Guo R Immunol Lett; 2013 Jun; 153(1-2):58-61. PubMed ID: 23892087 [TBL] [Abstract][Full Text] [Related]
52. Inflammatory signals in dendritic cell activation and the induction of adaptive immunity. Joffre O; Nolte MA; Spörri R; Reis e Sousa C Immunol Rev; 2009 Jan; 227(1):234-47. PubMed ID: 19120488 [TBL] [Abstract][Full Text] [Related]
53. [The role of T-regulatory cells in the pathogenesis of immunological disturbances accompanying obesity and atherosclerosis]. Luczyński W; Bossowski A; Głowińska-Olszewska B; Kos J; Stasiak-Barmuta A Postepy Hig Med Dosw (Online); 2010 Mar; 64():156-60. PubMed ID: 20354263 [TBL] [Abstract][Full Text] [Related]
54. Early events in Sjögren's Syndrome pathogenesis: the importance of innate immunity in disease initiation. Kramer JM Cytokine; 2014 Jun; 67(2):92-101. PubMed ID: 24656928 [TBL] [Abstract][Full Text] [Related]